This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seri, I.
Right arrow Articles by Evans, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seri, I.
Right arrow Articles by Evans, J.
Related Collections
Right arrow Premature & Newborn
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

PEDIATRICS Vol. 107 No. 5 May 2001, pp. 1070-1074

Cardiovascular Effects of Hydrocortisone in Preterm Infants With Pressor-Resistant Hypotension

Received May 10, 2000; accepted Aug 25, 2000.

Istvan Seri, Rosemarie Tan, and Jaquelyn Evans

From the Division of Neonatology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, Pennsylvania.

Objective.  To study the cardiovascular effects of hydrocortisone in preterm infants with hypotension unresponsive to volume and pressor administration.

Study Design.  Retrospective review of the cardiovascular response to 23 courses of hydrocortisone administration during the first day of treatment in 21 preterm infants (gestational age: 26.9 ± 3.9 weeks; postnatal age: 11.3 ± 13.1 days). Hydrocortisone (2 mg/kg/d in 16 patients and 3-6 mg/kg/d in 5 patients) was administered when dopamine (22.2 ± 11 µg/kg/min, range: 8-60) alone (n = 16) or in combination with dobutamine (8.4 ± 4.9 µg/kg/min, range: 5-20, n = 7) and/or epinephrine (0.38 ± 0.56 µg/kg/min, range: 0.01-1.2, n = 4) failed to normalize blood pressure.

Results.  Mean blood pressure increased from 29.3 ± 4.1 to 34.1 ± 5.2, 38.0 ± 8.0, and 41.8 ± 6.6 mm Hg by 2, 4, and 6 hours of hydrocortisone administration, respectively, and remained stable thereafter. Urine output increased despite a decrease in fluid administration during the first day of hydrocortisone treatment. The dose of dopamine and the number of patients receiving dobutamine and/or epinephrine also decreased during the same period. Eighteen of the 21 patients survived.

Conclusions.  Preterm infants with volume- and pressor-resistant hypotension respond to hydrocortisone with rapid normalization of the cardiovascular status and sustained decreases in volume and pressor requirement.  Key words:  blood pressure, dopamine, hydrocortisone, hypotension, preterm infant.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 PediatricsHome page
A. Pellicer, M. del Carmen Bravo, R. Madero, S. Salas, J. Quero, and F. Cabanas
Early Systemic Hypotension and Vasopressor Support in Low Birth Weight Infants: Impact on Neurodevelopment
Pediatrics, May 1, 2009; 123(5): 1369 - 1376.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
S. W. Aucott, K. L. Watterberg, M. L. Shaffer, P. K. Donohue, and for the PROPHET Study Group
Do Cortisol Concentrations Predict Short-Term Outcomes in Extremely Low Birth Weight Infants?
Pediatrics, October 1, 2008; 122(4): 775 - 781.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
P. C. Ng
Is There a "Normal" Range of Serum Cortisol Concentration for Preterm Infants?
Pediatrics, October 1, 2008; 122(4): 873 - 875.
[Full Text] [PDF]

Home page
 PediatricsHome page
K. L. Watterberg, M. L. Shaffer, M. J. Mishefske, C. L. Leach, M. C. Mammel, R. J. Couser, S. Abbasi, C. H. Cole, S. W. Aucott, E. H. Thilo, et al.
Growth and Neurodevelopmental Outcomes After Early Low-Dose Hydrocortisone Treatment in Extremely Low Birth Weight Infants
Pediatrics, July 1, 2007; 120(1): 40 - 48.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
S. Noori, P. Friedlich, P. Wong, M. Ebrahimi, B. Siassi, and I. Seri
Hemodynamic Changes After Low-Dosage Hydrocortisone Administration in Vasopressor-Treated Preterm and Term Neonates
Pediatrics, October 1, 2006; 118(4): 1456 - 1466.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
E. Valverde, A. Pellicer, R. Madero, D. Elorza, J. Quero, and F. Cabanas
Dopamine Versus Epinephrine for Cardiovascular Support in Low Birth Weight Infants: Analysis of Systemic Effects and Neonatal Clinical Outcomes
Pediatrics, June 1, 2006; 117(6): e1213 - e1222.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
N Evans
Which inotrope for which baby?
Arch. Dis. Child. Fetal Neonatal Ed., May 1, 2006; 91(3): F213 - F220.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
N. N. Finer, R. J. Powers, C.-h. S. Ou, D. Durand, D. Wirtschafter, J. B. Gould, and for the California Perinatal Quality Care Collabor
Prospective Evaluation of Postnatal Steroid Administration: A 1-Year Experience From the California Perinatal Quality Care Collaborative
Pediatrics, March 1, 2006; 117(3): 704 - 713.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
P. C. Ng, C. H. Lee, F. L. Bnur, I. H.S. Chan, A. W.Y. Lee, E. Wong, H. B. Chan, C. W.K. Lam, B. S.C. Lee, and T. F. Fok
A Double-Blind, Randomized, Controlled Study of a "Stress Dose" of Hydrocortisone for Rescue Treatment of Refractory Hypotension in Preterm Infants
Pediatrics, February 1, 2006; 117(2): 367 - 375.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
I. Seri
Hydrocortisone and Vasopressor-Resistant Shock in Preterm Neonates
Pediatrics, February 1, 2006; 117(2): 516 - 518.
[Full Text] [PDF]

Home page
 PediatricsHome page
A. Pellicer, E. Valverde, M. D. Elorza, R. Madero, F. Gaya, J. Quero, and F. Cabanas
Cardiovascular Support for Low Birth Weight Infants and Cerebral Hemodynamics: A Randomized, Blinded, Clinical Trial
Pediatrics, June 1, 2005; 115(6): 1501 - 1512.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
R. W. Hall, S. S. Kronsberg, B. A. Barton, J. R. Kaiser, K.J.S. Anand, and for the NEOPAIN Trial Investigators Group
Morphine, Hypotension, and Adverse Outcomes Among Preterm Neonates: Who's to Blame? Secondary Results From the NEOPAIN Trial
Pediatrics, May 1, 2005; 115(5): 1351 - 1359.
[Abstract] [Full Text] [PDF]

Home page
 NeoReviewsHome page
A. R. Stark
Pharmacology Review: Risks and Benefits of Postnatal Corticosteroids
NeoReviews, February 1, 2005; 6(2): e99 - e103.
[Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
D. Kaufman and K. D. Fairchild
Clinical Microbiology of Bacterial and Fungal Sepsis in Very-Low-Birth-Weight Infants
Clin. Microbiol. Rev., July 1, 2004; 17(3): 638 - 680.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. He, A. Varma, L. A. Weissfeld, and S. U. Devaskar
Postnatal glucocorticoid exposure alters the adult phenotype
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2004; 287(1): R198 - R208.
[Abstract] [Full Text] [PDF]

Home page
 NeoReviewsHome page
D. Osborn, N. Evans, and M. Kluckow
Diagnosis and Treatment of Low Systemic Blood Flow in Preterm Infants
NeoReviews, March 1, 2004; 5(3): e109 - 121.
[Full Text] [PDF]

Home page
 NeoReviewsHome page
S. Noori, P. Friedlich, and I. Seri
Pharmacology Review: The Use of Dobutamine in the Treatment of Neonatal Cardiovascular Compromise
NeoReviews, January 1, 2004; 5(1): e22 - 26.
[Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
S J Dasgupta and A B Gill
Hypotension in the very low birthweight infant: the old, the new, and the uncertain
Arch. Dis. Child. Fetal Neonatal Ed., November 1, 2003; 88(6): F450 - 454.
[Abstract] [Full Text] [PDF]

Home page
 NeoReviewsHome page
S. Noori, P. Friedlich, and I. Seri
Pharmacology Review: Developmentally Regulated Cardiovascular, Renal, and Neuroendocrine Effects of Dopamine
NeoReviews, October 1, 2003; 4(10): e283 - 288.
[Full Text] [PDF]

Home page
 NeoReviewsHome page
W. D. Engle and J. L. LeFlore
Hypotension in the Neonate
NeoReviews, August 1, 2002; 3(8): e157 - 162.
[Full Text] [PDF]